Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

CNS Pediatric Trials

New York

CNS trials open to children and teens in New York

27 CNS studies open to children and teens are recruiting participants at sites in 14 cities across New York as of November 18, 2026, according to ClinicalTrials.gov.

Call (888) 927-9530
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Browse New York by city

Cities with the most studies recruiting right now.

Every New York city with a recruiting study

By research area: Depression (9), Migraine (9), ADHD (4), Schizophrenia (3), Epilepsy (2).

New York (11), Amherst (6), Commack (3), Staten Island (3), Brooklyn (2), The Bronx (2), Buffalo (1), Glen Oaks (1), Great Neck (1), Lake Success (1), Port Jefferson Station (1), Rochester (1), Stony Brook (1), Syracuse (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

ADHD: recently updated in New York

Basic details from each study's public record (the 12 most recently updated of 27). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)

    • Phase 3
    • Ages 6 to 11
    • All sexes
    Sponsor
    Axsome Therapeutics, Inc.
    Recruiting in
    Staten Island
    Registry record
    NCT07717879 · updated
  2. Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)

    • Phase 3
    • Ages 12 to 17
    • All sexes
    Sponsor
    Axsome Therapeutics, Inc.
    Recruiting in
    Staten Island
    Registry record
    NCT07717892 · updated
  3. AWARE: Management of ADHD in Autism Spectrum Disorder

    • Phase 4
    • Ages 4 to 17
    • All sexes
    Sponsor
    Daniel Coury
    Recruiting in
    Rochester
    Registry record
    NCT05916339 · updated

Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in New York on ClinicalTrials.gov.

Depression: recently updated in New York

  1. Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus

    • No phase
    • Ages 12 to 22
    • All sexes
    Sponsor
    Michigan State University
    Recruiting in
    The Bronx
    Registry record
    NCT06232304 · updated
  2. Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

    • Phase 3
    • Ages 10 to 17
    • All sexes
    Sponsor
    Intra-Cellular Therapies, Inc.
    Recruiting in
    New York
    Registry record
    NCT06372964 · updated
  3. TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age

    • Observational
    • From 18 months, up to 11 years
    • All sexes
    Sponsor
    State University of New York at Buffalo
    Recruiting in
    Buffalo
    Registry record
    NCT07048574 · updated

Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in New York on ClinicalTrials.gov.

Migraine: recently updated in New York

  1. Randomized Study in Children and Adolescents With Migraine: Acute Treatment

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    Pfizer
    Recruiting in
    Amherst · Commack · Great Neck · and 2 more U.S. locations
    Registry record
    NCT04649242 · updated
  2. Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    Pfizer
    Recruiting in
    Amherst · Commack · New York
    Registry record
    NCT04743141 · updated
  3. Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    Pfizer
    Recruiting in
    The Bronx
    Registry record
    NCT05156398 · updated
  4. A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    H. Lundbeck A/S
    Recruiting in
    Commack
    Registry record
    NCT05164172 · updated
  5. A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

    • Phase 3
    • Ages 12 to 17
    • All sexes
    Sponsor
    AbbVie
    Recruiting in
    Amherst
    Registry record
    NCT06810505 · updated

Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in New York on ClinicalTrials.gov.

Schizophrenia: recently updated in New York

  1. Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder

    • Phase 3
    • Ages 5 to 17
    • All sexes
    Sponsor
    Intra-Cellular Therapies, Inc.
    Recruiting in
    New York · Staten Island
    Registry record
    NCT06229210 · updated

Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in New York on ClinicalTrials.gov.

Ask about studies in New York

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

This form is for adults. If you are under 18, please ask a parent or legal guardian to contact us.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that set an upper age limit, with at least half of the ages they accept under 18, as each study is coded in the registry.

CNS Pediatric Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-9530

or send a short form

This form is for adults. If you are under 18, please ask a parent or legal guardian to contact us.

How should we reach you?

Call